CorNova GmbH, a wholly-owned German subsidiary of CorNova, Inc. of Burlington, Mass, has received the CE Mark of approval for its Valecor(TM) Coronary Stent System.
The device, explained by the company:
The Valecor™ Coronary Stent System is an advanced cobalt-chromium stent system utilizing some of the thinnest struts available with a novel design that maximizes flexibility and conformability. The Valecor™ Coronary Stent System exhibits excellent deliverability to facilitate treatment to a large array of patients and lesions.
Designed to be the premier bare stent system on the market, the Valecor™ Coronary Stent System lives up to its name by truly delivering what other stent systems only claim. Using an advanced cobalt-chromium alloy, the Valecor™ offers superior strength and flexibility with minimal strut thickness, believed to significantly reduce restenosis. The Valecor™ design also provides for uniform expansion and minimal foreshortening. With its open cell architecture, the Valecor™ is the perfect device for use in the most complex of applications.